INTRODUCTION
Pathogenic, facultatively intracellular bacteria, such as Listeria, Salmonella, and Mycobacteria, are a global major health threat because they cause infections in human hosts leading to severe disease and death if untreated. Treatment nowadays is often complicated because of the massive increase in antimicrobial resistance (Prestinaci et al., 2015) . To survive in the host, pathogenic bacteria evolved multiple secreted or externally exposed virulence mediators that allow specific interaction with the host cell. These factors orchestrate the major steps in a bacterial virulence strategy, which help with adherence, cellular invasion, and, ultimately, the setup of a protective niche. The virulence factors enable interference with multiple biological pathways of the host, including host defense. Virulence allows enhanced bacterial multiplication or persistence in the host that causes tissue damage and disease. Finally, successful virulent bacteria manage to exit and transmit the infection to a new host (Webb and Kahler, 2008) . The virulence strategy of Listeria monocytogenes responsible is characterized by various mechanisms, including forced uptake even in nonphagocytic cells, such as epithelial cells. After uptake, they avoid lethal lysosomal degradation by a phagosomal escape mechanism, which is mainly promoted by their major virulence factor, listeriolysin O (LLO), supported by a few phospholipases. In the cytosol, Listeria rapidly multiply and specifically interact with the actin cytoskeleton to gain motility for cell-to-cell spreads (Cossart, 2011) .
On the other hand, the immune system evolved multiple strategies to fight bacterial pathogens. Innate immune mechanisms act in a coordinated fashion to restrict an infection. Among those, innate cytotoxic lymphocytes, in particular, natural killer and gd T cells are critical in the early defense against invading pathogens via the production of inflammatory cytokines and direct bactericidal activities (Gao and Williams, 2015; Gregory et al., 1996; Zheng et al., 2013) . Immune proteases, such as the neutrophil serine proteases, have been recognized to be essential for innate antibacterial immune defense (Stapels et al., 2015) . Mice deficient in cathepsin G and neutrophil elastase are greatly impaired in the elimination of gram-positive and gram-negative bacteria (Hahn et al., 2011; Hirche et al., 2008; Steinwede et al., 2012) .
We recently discovered that GzmB efficiently kills bacteria when delivered into the bacterial cytosol by the membrane disrupting protein, granulysin (GNLY) (Walch et al., 2014) . Although the concerted action of these two cytotoxic molecules seems an attractive model for the elimination of intracellular bacteria, multiple questions, particularly concerning the GNLY delivery mechanism, remain problematic. First, GNLY is not expressed in rodents (Krensky and Clayberger, 2009 ) despite their potent immunity against bacterial invaders, such as Listeria monocytogenes (Pamer, 2004) . Second, GNLY oddly displays virtually no membranolytic activity at the physiological NaCl concentration of 140 mM and neutral pH, questioning any contribution to antibacterial immune response in the extracellular space (Barman et al., 2006; Ernst et al., 2000) . Third, GNLY expression is exclusively limited to activated lymphocytes (Krensky and Clayberger, 2009 ). Therefore, GNLY will be predominantly released into immunological synapses between lymphocytes and bacterial-infected target cells. On the other hand, multiple cell types secrete Gzms, in particular GzmB, in response to inflammatory stimuli. This growing list includes myeloid cells, such as monocytes (Elavazhagan et al., 2015) , mast cells (Strik et al., 2007) , and neutrophils (Mattila et al., 2015; Wagner et al., 2008) , as well as plasmacytoid dendritic cells (Rissoan et al., 2002) and B cells (Hagn and Jahrsdorfer, 2012; Lindner et al., 2013) , and even non-immune cells, such as smooth muscle cells, keratinocytes, and chondrocytes (Boivin et al., 2009 ). Furthermore, extracellular granzymes are elevated in patients with bacterial infections (Lauw et al., 2000) . We therefore asked if there is a GNLY-independent antimicrobial activity of GzmB.
RESULTS

GzmB Cleaves Multiple Secreted or Membrane-Exposed Bacterial Virulence Factors
Without cytosolic delivery by GNLY, the Gzms can only target secreted or externally exposed bacterial proteins, known to be involved in virulence (Desvaux and Hebraud, 2006; Sharma et al., 2017) . When we treated Listeria monocytogenes (Lm), strain10403S, supernatants with GzmB, we found that two major virulence factors, listeriolysin O (LLO) and the invasion associated protein p60 (Iap), were efficiently degraded by the protease (Figure S1A ). Using an ectopic expression system and immunoblotting, we systemically tested the canonical, positive regulator factor A (PrfA)-dependent Lm virulence mediators (Scortti et al., 2007) in addition to Iap for GzmB susceptibility. GzmB cleaved most of these virulence factors. The exemptions were internalin C (InlC, very low efficiency, cleavage band only after longer GzmB exposure, Figure S2 ) and InlA (Figure 1 ). The degradation depended on GzmB activity as the presence of the specific GzmB inhibitor completely abrogated the cleavage of the highly susceptible substrate LLO ( Figure 1B ). Strikingly, GzmB most efficiently degraded the membranolytic factors, LLO, and the two major phospholipases, PlcA and PlcB. This suggested that two crucial steps in the Lm virulence strategy, the phagosomal escape and cell-to-cell spread (Seveau et al., 2007) , might be disrupted in response to GzmB. Five randomly picked cytosolic listerial proteins were not affected by the protease (Figure S1B ), suggesting specific targeting of secreted Lm virulence factors by GzmB. The unspecific serine protease, trypsin, degraded the Listeria virulence factors, LLO and Iap, as well as the cytosolic proteins, LipL and PurM, with high efficiency ( Figure 1C ) and even GST alone that was also not affected by GzmB ( Figure S1C ).
To exclude that the targeting of bacterial virulence mediators by the immune protease is a phenomenon specific to Lm, we assessed the impact of GzmB on various well-characterized secreted or externally exposed virulence mediators of Salmonella typhimurium, strain SL1344, and Mycobacteria tuberculosis, strain H37Rv. Surprisingly, GzmB degraded all of the tested bacterial factors ( Figure 1A ), although some of them with rather low efficiency. The full lanes of the cleavage blots are demonstrated in Figure S2 . However, bacterial factors essential for adhesion and invasion, such as the Salmonella invasion proteins SipA and SipC (Ibarra and Steele-Mortimer, 2009) or the mycobacterial Heparin-binding hemagglutinin (HbhA) (Forrellad et al., 2013) , were cleaved very efficiently, pointing again toward a defect early during infection in response to GzmB. As for Lm, randomly picked cytosolic control proteins of the other two bacterial strains were not degraded by the protease ( Figure S1B ) suggesting a specific attack on external bacterial virulence factors by GzmB.
GzmB Inhibits LLO Hemolytic Activity and Listeria Phagosomal Escape in Human Macrophages upon Co-endocytosis with Bacteria into Host Cells
The functional impact on LLO by GzmB-mediated degradation was assessed in hemolysis assays. For this purpose, purified recombinant LLO (Figure 2A ), as well as Lm supernatants containing secreted virulence factors ( Figure 2B ), was pretreated with GzmB before incubation with red blood cells to assess hemolytic activity. Indeed, GzmB mediated LLO degradation, verified by the decreased LLO signal intensity in immunoblots (and the appearance of typical cleavage fragments in Figure S3 ), and significantly inhibited the hemolytic activity, therefore disrupting the enzymatic function of this virulence mediator. LLO, supported by PlcA and PlcB, is essential for Lm phagosomal escape (Hamon et al., 2012) . After the escape, Lm interacts with actin to form comet-shaped tails that can be visualized and quantified by fluorescence microscopy using phalloidin staining. When we infected human macrophages under control conditions, most of the numerous intracellular bacteria displayed an actin tail 5 h post infection (Figures 2C and 2E) . However, when we infected the cells in the presence of GzmB, both the Listeria number and the actin recruitment of the intracellular bacteria were significantly reduced ( Figures 2D and 2E ). In addition, we found that, at the initial infection stage (1 h), the bacteria are covered by fluorescently labeled GzmB indicating co-endocytosis of the enzymes together with bacteria into host cells (Figures 2F and 2G) . This may lead to increased GzmB concentration in the bacteria-containing compartment during the initial infection and therefore facilitating virulence factor degradation.
GzmB Treatment during Infection Inhibits Growth of Intracellular Listeria and Salmonella in Human Macrophages in a Host Cell Death-Independent Manner
The microscopy experiments clearly suggested decreased bacterial load after infections in the presence of low-dose GzmB. However, for additional quantification, colony-forming unit (CFU) assays were necessary. For this purpose, human macrophages were infected with wild-type (WT) Lm or a strain lacking LLO (DLLO) at a multiplicity of infection of 10 in the presence or absence of GzmB or the unspecific protease, trypsin. At indicated times, the macrophages were hypotonically lysed and the bacterial CFUs enumerated on agar plates. CFU counts at the 1-h infection time point demonstrated no significant differences of the uptake A B C Figure 1 . GzmB Cleaves Secreted or Membrane-Exposed Bacterial Virulence Factors (A-C) (A) E. coli ectopically expressing GST-tagged Listeria monocytogenes, Salmonella typhimurium, or Mycobacteria tuberculosis proteins were treated with lysozyme and hypotonically lysed by freeze-thaw. Crude lysates were treated with indicated concentrations of GzmB for 20 min (A and B) or with the unspecific serine protease, trypsin (C), for 5 min before substrate cleavage was assessed by anti-GST immunoblots. To highlight both the decrease of the full-length protein and the appearance of cleavage fragments, some blots (SipC, SopE, HBhA, Hsp, ArfA, and Mce1B) were divided and presented at different exposure times. The full lanes at medium exposure times are shown in Figure S2 . In (B), the GzmB treatment of LLO was performed in the presence of the GzmB inhibitor Ac-IEPD-CHO. ) or Listeria monocytogenes-secreted proteins in supernatants (B) were treated with indicated concentrations of GzmB for 20 min before the protease was inactivated with DCI for 30 min on ice. These samples were used to treat human red blood cells for 15 min at 37 C. Hemoglobin release was measured spectrophotometrically at 405 nm wavelength by plate reader and is presented as average G SEM of three independent experiments. Cleavage of LLO assessed by immunoblot using an anti-LLO antibody. An overexposed image of the blot illustrating the cleavage fragments of native LLO in the supernatant after GzmB treatment is shown in Figure S3 . Human macrophages were infected with CFSE-labeled Listeria monocytogenes in the absence (C) or presence of 0.2 mM GzmB (D) before being fixed and stained with phalloidin-AF594 (red) and DAPI (blue). In (E), Listeria were counted and analyzed in 10 visual fields (n > 100) per condition in three independent experiments. HeLa cells were infected with PHK26 red-labeled Listeria monocytogenes in the presence of 0.2 mM GzmB-AF488 (F) or left untreated (G) before being fixed and stained with Hoechst (blue) for high resolution confocal microscopy analysis, bars are 10 mm. Representative maximum projections of z stack images (eight stacks, step size 0.5 mm) from independently repeated experiments are shown.
of the Lm strains into the host cells ( Figure 3A ). This was in sharp contrast to Lm infections in the presence of trypsin that significantly reduced the initial Listeria load in macrophages ( Figure S4A ). However, most of the macrophages detached from the surface during the trypsin treatment, which might hamper bacterial uptake. After the initial infection, the presence of GzmB significantly reduced the intracellular growth of WT Lm toward the range of the CFU counts of the severely attenuated DLLO bacteria ( Figure 3B ). Again, this was different from trypsin treatment where the growth of the few intracellular bacteria was not completely inhibited but was significantly reduced ( Figure S4B ). GzmB even further reduced the growth of DLLO bacteria suggesting that protease affected additional virulence that contributes to intracellular bacterial survival ( Figure 3B ). This intracellular growth inhibition in macrophages in response to GzmB was clearly due to attenuated bacterial virulence, rather than some other unspecific growth defect, as extracellular bacteria were not affected by the protease ( Figure 3C) , and, remarkably, also not by trypsin ( Figure S4C ).
As several important SL1344 virulence factors were efficiently destroyed by GzmB, we also performed growth assessment in CFU assays for intracellular Salmonella. Interestingly, the presence of GzmB already significantly inhibited the initial uptake of Salmonella suggesting that factors involved in binding and initial uptake might be particularly well targeted by the immune protease ( Figure 3D ). In addition, the intracellular growth of Salmonella in human macrophages was severely crippled in response to GzmB ( Figure 3E ). Again, this growth inhibition was observed only within host cells and extracellular Salmonella grew normally upon GzmB treatment ( Figure 3F ).
Confusingly, listeriolysin O was demonstrated to be capable of delivering the granzymes into target cells to induce cell death (Browne et al., 1999) . Therefore, we assessed caspase activation in response to Lm infection and GzmB using the highly sensitive M30 CytoDEATH antibody that detects caspase-cleaved cytokeratin 18 early in apoptosis (Leers et al., 1999) . Infections in the presence of GzmB induced no caspase activation ( Figure 3G ) as compared with infection only ( Figure 3J ). However, when we infected in the presence of GzmB and the efficient delivery protein perforin (PFN), we observed high caspase activity in almost all the cells after 4 h ( Figure 3H ). The PFN dose used was clearly sublytic as PFN-only treatment did not affect the host cells ( Figure 3J ). This striking difference might be explained by the use of recombinant LLO in the earlier study at concentrations that might not be reached by the endogenous virulence factor, in particular if GzmB degrades this factor upon secretion. Also, the simultaneous infection of these target cells might alter the susceptibility to lytic proteins by an increased membrane repair response as already observed in human dendritic cells upon Lm infections (Walch et al., 2007) .
However, our data confirm the published results that, for efficient bacterial killing, without the support of bystander cells, GzmB needs cytosolic delivery by GNLY (Dotiwala et al., 2017; Walch et al., 2014) . Moreover, these results additionally indicate that GzmB in a GNLY-independent manner attenuates bacterial virulence to help bystander cells eliminating the engulfed bacteria.
The Human Natural Killer Cell Line YT Indy Restricts the Growth of Intracellular Bacteria in a Gzm-Dependent Manner
Lm and Salmonella upon infection first enter intestinal epithelial cells (Lorkowski et al., 2014; Pizarro-Cerda et al., 2012) . Within the epithelial layer (Mayassi and Jabri, 2018) and in the lamina propria underneath (Fuchs and Colonna, 2011) , there are plenty of lymphocyte subsets, including gd T cells, that potentially secrete GzmB (Ogata and Itoh, 2016) . To test an experimental model that roughly mimics this initial invasion phase, we infected the human epithelial cell line, HeLa, in the presence of the natural killer (NK) lymphocytic line, YT Indy. YT Indy is a highly cytolytic human cell line that expresses vast amounts of GzmB and GzmH but not GzmA, GzmK, or GzmM (Su et al., 1994) . To do so, we infected HeLa cells with WT Lm of extracellular bacteria ( Figures 4C and 4F ). More importantly, pre-treatment of the killer cells with the serine protease inhibitor 3,4-dichloroisocoumarin (DCI) or the use of a YT Indy line (shYT Indy), silenced for GzmB and GzmH (Figures S5A and S5B) that we have recently established , abolished their impact on intracellular bacterial growth, suggesting involvement of the serine protease GzmB in this growth inhibition (Figures 4B and 4E) . Additionally, in support of the Gzms to be responsible for the growth inhibition was the observation that YT Indy cells secrete GzmB upon contact with bacteria as demonstrated by immunoblot ( Figure 4H ) and ELISA ( Figure 4I ). The GzmB secretion was at the same level as induced by the commonly used positive control treatments, such as PMA/Ionomycin (P/I), concanavalin A (ConA), and lipopolysaccharide (LPS) suggesting activation of pattern recognition receptors by the bacterial contact and subsequent calcium signaling (Hoving et al., 2014) as the trigger for the observed GzmB secretion. Importantly, the GzmB release was unaffected by the pretreatment with DCI ( Figure S5C ), indicating that the killer cells were not impaired by the serine protease inhibitor pretreatment and secrete most likely proteolytically inactivated enzymes. Together these data again suggest that the NK cell-derived Gzms cripple bacterial virulence, subsequently causing intracellular growth inhibition.
Short-Term Activated Primary Killer Lymphocytes Restrict the Growth of Intracellular Bacteria
To further challenge our hypothesis, we asked if short-term activated primary lymphocytes may restrict bacterial virulence and, with that, intracellular growth. As model cells, we chose lymphokine-activated killer (LAK) as well as gd T cells. Both cell models were demonstrated to display potent cytolytic activity in vitro (Rayner et al., 1985) , the latter also in the context of bacterial infections (Zheng et al., 2013) . Therefore, we infected human macrophages with SL1344 (Figures 5A and 5B) and Lm (Figures 5A and 5C) at an MOI of 10 in the presence of indicated primary killer cells at an effector:bacteria ratio of 10. We found an impaired bacterial uptake in the presence of gd T cells that fell just short of statistical significance ( Figure 5A ). However, intracellular bacterial growth was significantly reduced in response to the killer cells ( Figures 5B and 5C ). This bacterial growth restriction was not explained by direct inhibition of extracellular bacteria that were not affected by the killer cells ( Figure S6A ). Pretreatment of gd T cells with DCI, but not the presence of the GzmB inhibitor Ac-IEPD-CHO, significantly reduced their impact on intracellular Lm growth ( Figure 4C ), suggesting that various granzymes might contribute to the virulence attenuation. As for YT Indy cells ( Figures 4H and 4I ), we found an induction of the GzmB secretion in the supernatants from both cell types in response to the bacteria (Figures 5D, 5E , and S6B). As observed in infections assays in the presence of purified GzmB ( Figures 3G-3J ), the impaired intracellular bacterial growth was not caused by enhanced death of the infected host cells that were unaffected by the presence of killer cells during the infection procedure ( Figure 5F ).
gd T Cells and GzmB Inhibit the Growth of Mycobacterium bovis BCG in Human Macrophages in a TNF-Alpha-Independent Manner
A recent study observed mycobacterial growth inhibition in human macrophages that was mediated by GzmA secretion from gd T cells (Spencer et al., 2013) . We also infected human macrophages with Mycobacteria bovis BCG in presence of gd T cells and could indeed recapitulate the intracellular bacterial growth inhibition by CFU assays ( Figure 6A ). However, the cited study speculated about the underlying mechanism of the observed growth inhibition to be mediated by differential tumor necrosis factor alpha (TNF-a) expression that was driven by GzmA. Therefore, we also infected macrophages with Mycobacteria bovis BCG in the presence or absence of GzmB and measured intracellular bacterial growth by CFU assays and TNF-a secretion by ELISA. Although GzmB treatment during BCG infection of human macrophages impaired intracellular bacterial growth ( Figure 6B ), we could not detect significant differences in TNF-a levels in GzmB exposed versus non-exposed culture supernatants ( Figure 6C ). In our experimental model, TNF-a secretion was essentially driven by the bacterial infection and was not further enhanced by GzmB treatment. . Extracellular bacteria were grown in the infection medium in the presence or absence of YT Indy cells for 1 h and then diluted in appropriate bacterial broth for a continued incubation of 4 h (C and F). In (H), GzmB secretion from YT Indy cells after 4 h of co-incubation was assessed in immunoblots of the cellular supernatants using an anti-GzmB antibody. GzmB and GAPDH in the cellular pellet served as loading controls. Representative blots from independently repeated experiments are shown (see also Figure S5C ) The supernatants of two independent experiments were additionally analyzed by GzmB ELISA (I). As positive control activations during these assays served PMA/Ionomycin (P/I), lipopolysaccharide (LPS), and concanavalin A (ConA) treatment. For all CFU assays, averages GSEM are presented.
Expression of a GzmB Uncleavable LLO Mutant Rescued Listeria Virulence upon GzmB Treatment
To establish a causative link between a GzmB-mediated cleavage event and the observed decrease in virulence, we generated GzmB-uncleavable factor mutants (Martinvalet et al., 2008; Walch et al., 2014) . The most promising candidate for the generation of an uncleavable mutant was LLO, as this mediator is essential for Lm virulence (Hamon et al., 2012) , it has membranolytic activity that is easily assessed, and it is cleaved by GzmB with remarkably high efficiency. Analysis of GzmB cleavage sites using an N-terminal GST-LLO fusion protein by SDS-PAGE and Coomassie staining, as well as immunoblotting, revealed three dominant cleavage fragments ( Figure S7 ). The GzmB cleavage sites were identified to be D193, D200, and D416 by N-terminal sequencing, as well as by mass spectrometry analysis. After site-directed mutagenesis of these three aspartic acids into alanines, we integrated either wild-type LLO (rLLOwt) or the uncleavable For indicated experiments, the gd T cells were pretreated with DCI or the co-incubation was performed in the presence of the inhibitor Ac-IEPD-CHO. After removal of extracellular bacteria by PBS wash and gentamicin treatment, the infected cells were hypotonically lysed at indicated times and the CFU assessed on agar plates. CFU counts of three independent experiments after 1 h of infection are shown in (A). The CFU changes, normalized to the 1-h time point, are demonstrated in (B) and (C). GzmB secretion from indicated killer cells into the supernatants was assessed by GzmB immunoblots (D), as well as by GzmB ELISA (E). As positive control activation during these assays served PMA/Ionomycin (P/I) treatment. GzmB and GAPDH in the cellular pellet served as loading controls. Representative blots from independently repeated experiments are shown (see also Figure S6B ) In (F), BCECF-AM-prelabeled macrophages were infected with SL1344 G indicated killer cells. After washing and removal of extracellular bacteria by gentamicin treatment, at indicated times the released fluorescence in the supernatant of three independent experiments was assessed by plate reader and normalized to the no effector cell control to calculate host cell viability. For all data plots, averages GSEM are presented.
mutant LLO (rLLOmut) into the chromosome of the LLO-deficient Lm strain (DLLO), using the Listeria integration vector pIMK2 . Analysis of listerial culture supernatants indicated a similar secretion performance of the recombinant LLO proteins as that of wild-type LLO ( Figure 7A ). GzmB treatment of listerial supernatant demonstrated that, at a given GzmB concentration (0.2 mM) and exposure time (20 min), the uncleavable variant of LLO was protected from degradation, whereas Iap was still cleaved (Figure 7B) . Although the hemolytic activity of mutated recombinant LLO was somewhat, yet significantly, reduced compared with the wild-type form of the protein, it was not further impaired by the pre-treatment with GzmB ( Figure 7C ). The strain expressing mutated recombinant LLO also displayed a significant growth defect in human macrophages as compared with the wild-type version ( Figure 7D ). This reduced enzymatic activity of the mutated protein was likely due to the replacement of three aspartic acids with alanines that changes the charge of the hemolysin at the given pH. However, Lm expressing the uncleavable variant of the hemolysin grew significantly better as the line that integrated the empty vector only (p empty in Figure 7D) , rendering the mutated line a valuable tool to test virulent growth in response to GzmB. Indeed, when we infected human macrophages with these bacterial strains in the presence of low-dose GzmB, the growth of the listerial line expressing uncleavable mutant LLO was not further affected by GzmB (Figure 7E) , indicating that the GzmB-mediated degradation of this virulence factor caused the observed intracellular Listeria growth inhibition.
DISCUSSION
In this study, we present compelling evidence that virulence-related external proteins from Listeria monocytogenes, Salmonella typhimurium, and Mycobacteria tuberculosis are more efficiently targeted and destroyed by GzmB, compared with randomly picked cytosolic control proteins. The degradation of virulence factors can also be mediated by unspecific proteases, such as trypsin; the collateral tissue damage would be potentially much more dramatic compared with highly specific proteases, illustrated by nondiscriminating digestion of all tested proteins by trypsin, including GST. Virulence is a toolbox of mostly secreted or externally exposed factors that evolved in pathogenic bacteria to establish infections (Sparling, 1983; Webb and Kahler, 2008) . Virulent Listeria, Salmonella, and Mycobacteria use secreted or membrane-bound adhesion factors, called internalins (Inl), Salmonella invasion proteins (Sip), or mycobacterial adhesins, such as HbhA, and many others to bind and invade phagocytes and non-phagocytic cells, such as epithelial cells (Bierne et al., 2007; Ibarra and Steele-Mortimer, 2009; Squeglia et al., 2018) . After uptake, Listeria escape the endosomes/phagosomes using membranolytic toxins, LLO and PlcA + PlcB, to avoid degradation in the lysosomal compartment (Cossart, 2011) . Salmonella employ factors that impact on positioning of the phagosome, such as SipC and SopE, to avoid phagosome maturation and lysosomal fusion (Forrellad et al., 2013; Jantsch et al., 2011) . Additionally, Salmonella and Mycobacteria can also release radical degrading enzymes, such as AhpC, the caseinolytic proteases (Clp), or catalase, to resist low pH and oxidative and nitrosative stress in the harsh environment of the phagosomes (Forrellad et al., 2013; Ibarra and Steele-Mortimer, 2009 ). Ultimately, these mechanisms enable the facultative intracellular bacteria to escape the hostile environment in the extracellular space where a multitude of innate and adaptive immune defense mechanisms can potentially harm bacterial pathogens. Simultaneously, virulence factors of these facultative intracellular bacteria promote prolonged survival in specialized immune cells by inhibiting their bactericidal mechanisms, the cell death machinery (Robinson and Aw, 2016), or the instruction of an adaptive immune response (Zhai et al., 2019) . Considering (C-E) (C) Listeria-primed supernatants were pretreated with indicated concentrations of GzmB for 20 min as in Figure 2A before treating human red blood cells for 15 min at 37 C. Hemoglobin release was measured spectrophotometrically at 405 nm wavelength. Indicated Listeria mutants were infected in the absence (D) or presence of 0.2 mM GzmB (E) before the intracellular bacterial load was assessed at indicated time points by CFU assay. Averages GSEM are presented.
the crucially important functions of these factors, it seems highly likely that the degradation of several of these proteins would severely cripple intracellular growth of inflicted bacteria.
Therefore, from a host perspective, it would seem like an efficient counterstrategy to target specifically these virulence mediators that are visible and potentially vulnerable to host defense mechanisms. Indeed, the immune system evolved various mechanisms to fight bacterial virulence. Secreted immunoglobulin A (IgA) interferes with bacterial invasion and adhesion by targeting surface exposed factors (Lamm, 1997) , in addition to triggering the complement cascade to eliminate the pathogens (Heesterbeek et al., 2018) . Pattern recognition receptors (PRRs) bind bacterial endotoxins and other surface exposed factors to mount an inflammatory response and to alarm the host defense (Heumann and Roger, 2002) . Many acute phase proteins directly counteract bacterial siderophores by the sequestration of iron during infections (Parrow et al., 2013) .
Immune proteases are crucial for antibacterial defense. Neutrophil elastase and cathepsin G are indispensable for the elimination of engulfed pathogens, probably in cooperation with microbicidal peptides and oxygen radicals produced by the NADPH oxidase (Korkmaz et al., 2008) . How these innate immune proteases actually kill bacteria was not well defined. However, proteases may directly interfere with bacterial virulence as they can degrade bacterial factors and consequently attenuate bacterial virulence and pathogenicity.
We recently discovered that the granzymes rapidly kill bacteria when delivered into the bacterial cytosol by the antimicrobial protein GNLY (Walch et al., 2014) . This rapid killing was triggered by the proteolytic degradation of vital bacterial proteins, such as the components of the respiratory chain, radical oxygen degrading enzymes, and the protein synthesis machinery (Dotiwala et al., 2017; Walch et al., 2014) . However, to induce this death pathway, the two cytotoxic effector molecules have to act in a highly coordinated manner. As GNLY is expressed only in activated lymphocytes (Krensky and Clayberger, 2009 ), this exclusive cooperation is predominantly given during a cytotoxic lymphocyte attack against bacterial infected target. To do so, cytotoxic lymphocytes need to recognize and bind infected target cells to release the two effectors together with yet another pore-forming protein, perforin, to primarily shuttle GNLY and GzmB into the infected target cell (Froelich et al., 1996) . Specific cytotoxic lymphocyte attacks are core features of adaptive immunity. They mount on established bacterial infections and are time consuming.
In the present study, we reveal a synergistic antibacterial activity of the granzymes during innate immunity that acts at the starting point of an infection by targeting bacterial virulence. We present here a function of extracellular Gzms that is independent of GNLY-mediated delivery into the bacterial cytosol. GzmB cleaves with remarkably high efficiency secreted bacterial virulence mediators, such as Listeria LLO and Salmonella SipA, SipC, and FljB. The efficient proteolytic degradation of these crucially important bacterial factors by GzmB is corroborated by numerous functional assays, demonstrating impaired Listeria phagosomal escape, drastically decreased Salmonella load early in the infection, as well as impaired intracellular bacterial growth in epithelial cells and macrophages.
Interestingly, in agreement with our findings, these virulence molecules during the infection of neutrophils are also efficiently degraded by innate immune proteases, such as the neutrophil metalloproteinase-8 (Arnett et al., 2014) and neutrophil elastase (Weinrauch et al., 2002) , respectively, highlighting the evolutionary relevance of this host-pathogen interactions. More recently, it was demonstrated that neutrophils in response to Mycobacteria infection up-regulate in vivo GzmB (Mattila et al., 2015) that might also contribute to bacterial killing by targeting virulence as GNLY is not co-expressed. Our results reveal an unexpected function of innate cytotoxic lymphocytes exerted by the release of the granzymes in limiting the bacterial cellular entry as well as in impairing bacterial intracellular growth in established infections. The inhibition of intracellular bacterial growth was not explained by increased cell death or by the increased secretion of proinflammatory cytokines, such as TNF-a, from the host cells in the presence of extracellular granzymes or killer lymphocytes.
Exemplified with the major Listeria virulence mediator LLO, we conclusively demonstrate that GzmB destroys the membranolytic function of this factor, which is a prerequisite of the phagosomal escape. Indeed, when infected in the presence of GzmB, Listeria fail to multiply in macrophages and do not recruit the actin cytoskeleton. Importantly, the generation of an uncleavable form of LLO rescues hemolytic activity and intracellular replication in the presence of GzmB, causatively linking a single Gzm-mediated virulence factor destruction with impaired virulent behavior in host cells.
Mechanistically, we demonstrate in co-uptake assays with fluorescently labeled GzmB that the positively charged protease binds to the negatively charged bacterial surface to be co-endocytosed into host cells. The co-endocytosis will increase the GzmB concentration in the bacteria-containing intracellular compartment where the protease continues to degrade externalized virulence factors and therefore to impair virulence. The probably less efficient co-endocytosis of uncharged trypsin might therefore explain our result that the presence of trypsin during the infection impairs intracellular Listeria growth less efficiently than GzmB, although it is proteolytically more active in cleavage assays.
Overall, in a more physiological context, we think that this immune mechanism might be important at mucosal surfaces where intraepithelial lymphocytes and potentially other cell types secrete GzmB in response to bacterial invaders or inflammatory stimuli (Olivares-Villagomez and Van Kaer, 2018) . Extracellular GzmB will then degrade external virulence mediators to disarm the invading bacterial pathogens and subsequently enable bystander immune and non-immune cells to eliminate the bacteria.
Limitations of the Study
In this work, we reveal an antimicrobial function of GzmB by efficiently destroying secreted bacterial virulence mediators under in vitro conditions. We hypothesize that this antimicrobial mechanism might be particularly important at mucosal surfaces where invading bacteria might trigger the release of Gzms by intraepithelial lymphocytes (IELs) or lamina propria cells and thus limit bacterial virulence and further spread. A major limitation of this study is therefore the absence of any in vivo proof. There are five Gzms in humans and even 10 Gzms in mice with overlapping substrate specificities; therefore, single gene knockdown will likely have no effect. However, a mouse model deficient for the major Gzms expressed in IELs could be challenged orally with bacteria to assess their invasiveness and ability to induce systemic disease. Depletion of IELs in mice was already demonstrated to impair Salmonella clearance (Li et al., 2012) ; however, the underlying mechanism was not solved in this study. Another question that remains unanswered is what happens to extracellular bacteria, such as Staphylococcus aureus, Pseudomonas aeruginosa, or pathogenic E. coli (EPEC). Could the Gzms also attenuate the virulence of extracellular bacteria and therefore increase their susceptibility to defense mechanisms, such as complement lysis or the lethal engulfment by phagocytes?
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file. S2. GzmB targets bacterial effectors, full lanes. Related to Figure 1 . 
SUPPLEMENTAL INFORMATION
Transparent Methods
Experimental Model Details
In vitro generation of human primary cells and cell culture conditions
Human primary cells cells were generated in vitro from peripheral blood mononuclear cells (PBMC) isolated from buffy coats of healthy blood donors (Blood bank, Bern, Switzerland) by Ficoll-Paque™ PLUS (GE Healthcare) density centrifugation. PBMCs were cultured in H5 (RPMI supplemented with 5% heat inactivated human serum (Blood bank, Bern, Switzerland)) and 1% antibiotic/antimycotic solution (Thermo Fisher) for 1 hours at 37°C to allow adhesion of the monocytes. After the incubation, the non-adherent suspension cells were collected and further cultured in H5 supplemented with 5 M zoledronate (Sigma) + 200 U/ml recombinant human IL-2 (Miltenyi) for 14 days according to (Kondo et al., 2011) to obtain T cells. The cells were diluted and supplemented with fresh IL-2 every 2-3 days. For phenotyping after the expansion, cells were stained with fluorescently conjugated anti TCR (BD) and assessed by flow cytometry (BD Accuri C6). The frequency of the T cells increased routinely to over 70% during the expansion (data not shown). Lymphokine-activated killer (LAK) cells were generated by culture in H5 supplemented with 200 U/ml recombinant human IL-2 for 14 days according to (Groscurth et al., 1990) .
The adherent PBMCs were cultured in H5 for at least 7 days to obtain macrophages (Aurore et al., 2018) .
HeLa cells were cultured in DMEM and YT Indy cells in RPMI, both supplemented with 10% FBS (Sigma) and 1% antibiotic/antimycotic solution (Thermo Fisher). For the culture of the shYT Indy line 2 g/ml puromycin (Sigma) was added .
Bacterial Strains
Listeria monocytogenes 10403S, Salmonella Typhimurium SL1344 and Mycobacteria bovis BCG used for infections were grown to mid-log in appropriate medium (Brain Heart Infusion + 50 g/ml streptomycin for Listeria; Luria broth + 50 g/ml streptomycin for Salmonella; Middlebrook 7H9 Broth supplemented with OADC und Tween 80 for Mycobacteria). 50 g/ml Kanamycin was added to grow mutant Listeria (pIMK2 transfected).
Methods Details
Study design
The objective of this study was to identify GNLY independent mechanisms of Gzm antibacterial activity. Without cytosolic delivery by GNLY, the Gzms can only interact with a limited fraction of the bacterial proteins. Therefore, a panel of well-established secreted or externally exposed bacterial virulence mediators were tested for their susceptibility towards GzmB. Bacterial virulent growth after treatment with purified GzmB or Gzm secreting killer cells was tested in primary human macrophages as well as in HeLa cells. A GzmB uncleavable virulent factor was generated to causatively link a Gzm cleavage event with bacterial virulence.
GzmB and PFN Purification
Native human GzmB and perforin was purified from the human NK cell line YT-Indy as described (Lopez Leon et al., 2017) . In brief, YT Indy cells were grown in complete medium to about 3x10 9 cells and harvested by centrifugation. The cellular pellet was resuspended in ice-cold relaxation buffer (10 mM PIPES, 0.1 M KCl, 3.5 mM MgCl 2 , 1 mM ATP, 1.25 mM EGTA, 0.05% BSA, pH 6.8) and disrupted in a nitrogen cavitation bomb at 35 bar at 4°C for 15 minutes. Unbroken cells and nuclei were removed by centrifugation (400 × g for 7 minutes at 4°C) and the post-nuclear supernatant was spun (15000 × g for 15 minutes at 4° C) to yield the granule pellet. The granule proteins were extracted by repeated freeze/thaw in extraction buffer (1 M NaCl in 20 mM Naacetate, pH 4.5 containing 2 mM EGTA; 1 ml per 3x10 9 cells) and the resulting lysate was centrifuged (15000 × g for 10 minutes at 4°C) and filtered (0.45-m syringe filter, Millipore).
For GzmB purification, the granule extract was diluted (1:20) in S column buffer (50 mM bisTris, 50 mM NaCl, pH 5.8, filtered), load on a S column (HiTrap SP HP; GE) and eluted using a linear NaCl gradient (to 1M). GzmB activity was determined colormetrically using N-Ac-IEPD-pNA (Sigma) in a microplate reader (Synergy H1, Biotek).
For PFN purification, the granule extract was buffer exchanged to PFN-IMAC buffer (1 M NaCl, 20 mM HEPES, 10% betaine, pH 7.4, filtered) using an Econo-Pac 10 DG column (BioRad), then load on a cobalt-IMAC column (HiTrap IMAC HP 5 ml; GE) and eluted on a linear imidazole gradient (to 500 mM). The hemolytic activity of PFN was determined in assay buffer (10 mM Hepes, 0.15 M NaCl, and 0.1% BSA, pH 7.5) incubated with an equal volume of 0.2% human red blood cells in assay buffer containing 5 mM CaCl2 at 37°C for 15 min. The hemoglobin released into the supernatant was detected in a microplate reader (Synergy H1, Biotek). See also hemolysis assays below.
Hemolysis assays
In u-bottomed microtiter plates, recombinant GST-LLO (50 M) or secreted proteins in the Listeria culture supernatant were treated with indicated concentration of GzmB or same volume of PBS as control for 20 minutes before 3,4-dichloroisocoumarin (DCI; Sigma) to a final concentration of 50 M was added and the samples were incubated on ice for 30 minutes. Human red blood cells (RBCs, Swiss Blood Bank, Bern Switzerland) were washed 3 times and diluted to a hematocrit of 0.2% in acidic hemolysis buffer (100 mM NaCl, 40 mM NaPO4, 0.5 mg/ml BSA, pH=5.5). An equal volume of diluted RBCs was added to the hemolysins in the microtiter plates and incubated at 37° C for 15 minutes. After the incubation, the plate was spun (500 x g, 3 minutes) and the supernatant was transferred to a flat-bottomed microtiter plate. Hemolysis was assessed by absorbance readings at 405 nm in a plate reader (Synergy H1, Biotek). Specific hemolysis was normalized to positive control lysis induced by 0.1% Triton X-100, corrected by the spontaneous hemoglobin release in buffer only conditions.
Bacterial infections, colony forming unit (CFU) assays, microscopy and TNF- ELISA
Before infections, bacteria were washed with PBS, resuspended in infection medium (RPMI + 1% BSA + appropriate antibiotics as above) and the OD at 600 nm wavelength was measured to estimate cell density (OD600 = 0.1 corresponds to ~2x10 7 bacteria /ml). For microscopy, Listeria were stained with 2 M CFSE (Sigma) for 30 minutes on ice or with the PKH26 Red Fluorescent Cell Linker kit (Sigma) for 5 minutes at room temperature, washed three times with PBS and resuspended in infections medium. Macrophages and HeLa cells were seeded at a density of 10 5 cells in 500 l on glass coverslips in 24-well plates and infected with labeled-Listeria in presence of 0.2 M GzmB or not as above. After a PBS wash, cells were incubated for 4.5 hours in infection medium + gentamicin, and then fixed with 1.5% paraformaldehyde in PBS.
Macrophages and HeLa cells were infected with
Fixed cells were washed twice with PBS and then stained with phalloidin-AF594 (150 nM, ThermoFisher) and DAPI (1 g/ml, Sigma) for 30 minutes at room temperature in the dark.
To assess cell death, infected cells were fixed in cold methanol (-20° C) for 15 minutes, washed twice with PBS and then stained with the CytoDEATH M30 antibody (Roche) and Hoechst (1 g/ml, Sigma) for 1 hour at room temperature in the dark. After the primary antibody, cells were washed with PBS and then counterstained with anti-mouse IgG-AF594 (R&D Systems) for 30 minutes at room temperature.
To assess co-endocytosis, HeLa cells were infected with red-labeled Lm in presence of GzmB-AF488 as above. After PFA fixation, cells were stained with Hoechst (1 g/ml, Sigma) for 30 minutes at room temperature in the dark.
All stained cover slips were washed twice with PBS before mounting in vectashield (vectorlabs) and analysis by confocal microscopy (Leica SP5).
TNF- levels were measured by subjecting serial dilutions of BCG infected macrophage supernatants to sandwich ELISA (R&D Dual kit) according to the manufacturer's recommendations
Assessment of GzmB secretion by killer cells in response to bacterial exposure by immunoblot and ELISA
Killer cells (YT Indy, activated T cells, LAK cells) were incubated for 60 minutes at 37° C with Lm or Salmonella SL1344 at a bacteria-lymphocyte ratio of 1:10 and then centrifuged (400 x g, 10 minutes) to separate the cellular pellet from the supernatant that was additionally filtered (0.45 m). The pellet was lysed in RIPA buffer. Supernatant and pellet were assessed by immunoblots using mouse anti-GzmB (clone B18.1; Enzo Life Sciences) and mouse anti-actin antibodies (Thermofisher), respectively, (in Figures S5 and S6) ; or using rat anti-GzmB (clone 496B, Invitrogen) and rabbit anti-GAPDH (Sigma), in Figures 4 and 5. All secondary HRP-conjugated antibodies were purchased from R&D Systems. Blots were analyzed using the Syngene G:Box F3 imager.
GzmB levels were measured by subjecting serial dilutions of activated killer cell supernatants to sandwich ELISA (R&D Dual kit) according to the manufacturer's recommendations
Assessing host cell viability in response to SL1344 infection by BCECF fluorescence release assays
Fluorescence release assays using BCECF-AM (Sigma) were performed according to (Aurore et al., 2018) . Briefly, human macrophages, seeded in flat-bottom 96-well microplates, were labelled before the infection with 2,7-Bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM; Sigma) for 30 minutes in RPMI at 37° C (Kolber et al., 1988) . After three washes with PBS, the cells were infected with SL1344 as above. After removal of extracellular bacteria by gentamicin treatment, the released fluorescence at indicated time points was measured in the supernatant by plate reader at the 488-Exitation/530-Emission setting.
Assessment of bacterial substrate cleavage, production of recombinant LLO and priming of
Listeria supernatants E. coli Bl21 harboring GST-fusion protein in pGEX4Ti were induced for 60 minutes at 37°C with 0.25 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) in LB containing 100 μg ampicillin and 2% glucose, then were washed, resuspended in 20 mM NaCl, 10 mM Tris, pH 7.4 supplement with 0.1 mg/ml lysozyme (Sigma) and incubated for 30 min on ice. After three freeze and thaw cycles, the crude lysates were treated with indicated concentration of GzmB for 30 min or with trypsin (from bovine pancreas, Sigma) for 5 minutes on 37° C. Reactions were stopped by boiling in SDS-PAGE loading buffer. Samples were analyzed by immunoblot using mouse anti-GST antibody (BD). For the assessment of LLO hemolytic activity and the identification of GzmB cleavage sites, GST-tagged LLO was purified using a GSTrap HP column (GE Healthcare) following the manufacturer`s recommendations.
To assess the degradation of native secreted proteins, Listeria cultures were grown to the mid-log phase, washed 3 times with PBS and resuspended in RPMI. Listeria in RPMI were incubated in a shaking incubator at 37° C for 1 to 4 hours before the supernatant was cleared by centrifugation (1000 x g for 5 minutes) and filtration (0.45 m). Cleared supernatants were treated with GzmB as above and analyzed by immunoblot using mouse anti-Iap (p60, antibodies-online.com) and rabbit anti-LLO antibodies (Abcam). Secondary HRP-conjugated antibodies were from R&D Systems. Blots were analyzed using the Syngene G:Box F3 imager.
Generation of a GzmB-uncleavable LLO mutant and expression in a LLO-deficient Listeria
strain GST-tagged LLO was treated with 0.2 M GzmB for 20 minutes before the cleavage sites were visualized by SDS-PAGE and Coomassie staining and anti-GST immunoblots. The N-terminal cleavage sites were analyzed by Mass Spec (Proteomics core facility, University of Fribourg, Switzerland). The C-terminal fragments were subjected to N-terminal sequencing (PROTEIN ANALYTICS, University of Giessen, Germany). The three dominant cleavage site aspartic acids were mutated to alanines by two-step overlap PCR. Full-length (including the natural ribosome binding site) wild-type and mutated LLO was cloned into pIMK2 at the BamH1/Xho1 sites and then transfected into LLO-deficient Listeria.
Statistics
All experiments were performed in triplicates and were at least once independently repeated. Data are presented as means ± SEM. Comparisons between the different groups were performed with two-tailed unpaired Student`s t tests (using Microsoft Excel). P values are indicated in the Figures. P values of less than 0.05 were considered significant.
